IRD earnings: a negative outcome, -16.7%

On May 15, 2023, Opus Genetics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -16.7% in the window around the event. It had already run +12.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.